NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Instapath Inc.

Instapath Inc.

Private
Houston, TexasHealthcare & Life Scienceshttps://instapathbio.com/

Last Round

Grant

Mar 1, 2021

Est. Valuation

$2.14M

Total Funding Raised

$6.14M

Company Overview

Instapath Inc. is a medical technology company that develops microscopy systems for rapid, slide-free digital pathology to enable faster cancer diagnosis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

digital pathologypathology imagingintraoperative consultationtissue biopsymedical imagingpoint-of-care pathologyrapid diagnosticsfluorescence microscopyslide scanningmedical devicepathology lab equipmentfrozen section alternativereal-time pathology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Instapath Inc. Comparables

Compare Instapath Inc. with similar companies based on industry and business-model similarity.

Instapath Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Histolix, Inc.
90%
Invenio Imaging
86%
MUSE Microscopy, Inc.
86%

Instapath Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 1, 2021
SeedSep 17, 2019
SeedMar 18, 2019
GrantFeb 21, 2019
GrantJul 1, 2018
Accelerator
Apr 1, 2018

Key People

Founding team and executive leadership

Mei Wang

CEO, Cofounder

Founding Team

David Tulman

Chief Clinical Officer, Chief Operating Officer

Executive Team

Instapath Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Monthly visitors grew 699% MoM, from 134 to 1.1K.

  • Mar 1, 2021

    $1M grant awarded by the National Science Foundation.

Instapath Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Instapath Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Instapath Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersHouston, Texas
Employee Range7
Year Founded2017
Last FundingMar 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.